Chloroquine-resistant falciparum malaria from Malawi.
A case of falciparum malaria from Malawi is reported. RII resistance to chloroquine according to WHO standards is proven. This is the first case of chloroquine-resistance, assessed according to WHO standards, reported from Malawi.
D000328:Adult; D002738:Chloroquine / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008295:Malawi; D008297:Male; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use
D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine